Home >> Life Sciences >> Healthcare

North America Restriction Endonucleases Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Published: May-2017 | Format: PDF | Global Info Research | Number of pages: 120 | Code: MRS - 127175

Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.


Scope of the Report:
This report focuses on the Restriction Endonucleases in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
    New England Biolabs
    Thermo Fisher Scientific
    Takara Bio
    Illumina
    Agilent Technologies
    Roche
    GE Healthcare
    Promega Corporation
    Qiagen
    Jena Biosciences

Market Segment by Countries, covering
    United States
    Canada
    Mexico

Market Segment by Type, covers
    Type I
    Type II
    Type III
    Type IV
    Others

Market Segment by Applications, can be divided into
    Academic & Research Institutes
    Hospitals & Diagnostic Centers
    Biopharmaceutical
    Other

There are 15 Chapters to deeply display the North America Restriction Endonucleases market.

Chapter 1, to describe Restriction Endonucleases Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Restriction Endonucleases, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Restriction Endonucleases, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Restriction Endonucleases market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Restriction Endonucleases Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents
1 Market Overview
    1.1 Restriction Endonucleases Introduction
    1.2 Market Analysis by Type
        1.2.1 Type I
        1.2.2 Type II
        1.2.3 Type III
        1.2.4 Type IV
        1.2.5 Others
    1.3 Market Analysis by Applications
        1.3.1 Academic & Research Institutes
        1.3.2 Hospitals & Diagnostic Centers
        1.3.3 Biopharmaceutical
        1.3.4 Other
    1.4 Market Analysis by Countries
        1.4.1 United States Status and Prospect (2012-2022)
        1.4.2 Mexico Status and Prospect (2012-2022)
        1.4.3 Canada Status and Prospect (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 New England Biolabs
        2.1.1 Profile
        2.1.2 Restriction Endonucleases Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.1.4 Business Overview
        2.1.5 New England Biolabs News
    2.2 Thermo Fisher Scientific
        2.2.1 Profile
        2.2.2 Restriction Endonucleases Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.2.4 Business Overview
        2.2.5 Thermo Fisher Scientific News
    2.3 Takara Bio
        2.3.1 Profile
        2.3.2 Restriction Endonucleases Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.3.4 Business Overview
        2.3.5 Takara Bio News
    2.4 Illumina
        2.4.1 Profile
        2.4.2 Restriction Endonucleases Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.4.4 Business Overview
        2.4.5 Illumina News
    2.5 Agilent Technologies
        2.5.1 Profile
        2.5.2 Restriction Endonucleases Type and Applications
            2.5.2.1 Type 1
            2.5.2.2 Type 2
        2.5.3 Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.5.4 Business Overview
        2.5.5 Agilent Technologies News
    2.6 Roche
        2.6.1 Profile
        2.6.2 Restriction Endonucleases Type and Applications
            2.6.2.1 Type 1
            2.6.2.2 Type 2
        2.6.3 Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.6.4 Business Overview
        2.6.5 Roche News
    2.7 GE Healthcare
        2.7.1 Profile
        2.7.2 Restriction Endonucleases Type and Applications
            2.7.2.1 Type 1
            2.7.2.2 Type 2
        2.7.3 GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.7.4 Business Overview
        2.7.5 GE Healthcare News
    2.8 Promega Corporation
        2.8.1 Profile
        2.8.2 Restriction Endonucleases Type and Applications
            2.8.2.1 Type 1
            2.8.2.2 Type 2
        2.8.3 Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.8.4 Business Overview
        2.8.5 Promega Corporation News
    2.9 Qiagen
        2.9.1 Profile
        2.9.2 Restriction Endonucleases Type and Applications
            2.9.2.1 Type 1
            2.9.2.2 Type 2
        2.9.3 Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.9.4 Business Overview
        2.9.5 Qiagen News
    2.10 Jena Biosciences
        2.10.1 Profile
        2.10.2 Restriction Endonucleases Type and Applications
            2.10.2.1 Type 1
            2.10.2.2 Type 2
        2.10.3 Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.10.4 Business Overview
        2.10.5 Jena Biosciences News
3 North America Restriction Endonucleases Market Competition, by Manufacturer
    3.1 North America Restriction Endonucleases Sales and Market Share by Manufacturer (2016-2017)
    3.2 North America Restriction Endonucleases Revenue and Market Share by Manufacturer (2016-2017)
    3.3 North America Restriction Endonucleases Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Restriction Endonucleases Manufacturer Market Share
        3.4.2 Top 5 Restriction Endonucleases Manufacturer Market Share
    3.5 Market Competition Trend
4 North America Restriction Endonucleases Market Analysis by Countries
    4.1 North America Restriction Endonucleases Sales Market Share by Countries
    4.2 North America Restriction Endonucleases Sales by Countries (2012-2017)
    4.3 North America Restriction Endonucleases Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Restriction Endonucleases by Type
    5.1 North America Restriction Endonucleases Sales, Revenue and Market Share by Type (2012-2017)
        5.1.1 North America Restriction Endonucleases Sales and Market Share by Type (2012-2017)
        5.1.2 North America Restriction Endonucleases Revenue and Market Share by Type (2012-2017)
    5.2 Type I Sales Growth and Price
        5.2.1 North America Type I Sales Growth (2012-2017)
        5.2.2 North America Type I Price (2012-2017)
    5.3 Type II Sales Growth and Price
        5.3.1 North America Type II Sales Growth (2012-2017)
        5.3.2 North America Type II Price (2012-2017)
    5.4 Type III Sales Growth and Price
        5.4.1 North America Type III Sales Growth (2012-2017)
        5.4.2 North America Type III Price (2012-2017)
    5.5 Type IV Sales Growth and Price
        5.5.1 North America Type IV Sales Growth (2012-2017)
        5.5.2 North America Type IV Price (2012-2017)
    5.6 Others Sales Growth and Price
        5.6.1 North America Others Sales Growth (2012-2017)
        5.6.2 North America Others Price (2012-2017)
6 North America Market Segmentation Restriction Endonucleases by Application
    6.1 North America Restriction Endonucleases Sales Market Share by Application (2012-2017)
    6.2 Academic & Research Institutes Sales Growth (2012-2017)
    6.3 Hospitals & Diagnostic Centers Sales Growth (2012-2017)
    6.4 Biopharmaceutical Sales Growth (2012-2017)
    6.5 Other Sales Growth (2012-2017)
7 United States Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers
    7.1 United States Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
    7.2 United States Restriction Endonucleases Sales and Market Share by Type
    7.3 United States Restriction Endonucleases Sales by Application (2012-2017)
    7.4 United States Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer
        7.4.1 United States Restriction Endonucleases Sales and Market Share by Manufacturer
        7.4.2 United States Restriction Endonucleases Revenue and Market Share by Manufacturer
    7.5 United States Restriction Endonucleases Export and Import (2012-2017)
8 Canada Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers
    8.1 Canada Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
    8.2 Canada Restriction Endonucleases Sales and Market Share by Type
    8.3 Canada Restriction Endonucleases Sales by Application (2012-2017)
    8.4 Canada Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer
        8.4.1 Canada Restriction Endonucleases Sales and Market Share by Manufacturer
        8.4.2 Canada Restriction Endonucleases Revenue and Market Share by Manufacturer
    8.5 Canada Restriction Endonucleases Export and Import (2012-2017)
9 Mexico Restriction Endonucleases Sales, Revenue, by Type, Application and Manufacturers
    9.1 Mexico Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
    9.2 Mexico Restriction Endonucleases Sales and Market Share by Type
    9.3 Mexico Restriction Endonucleases Sales by Application (2012-2017)
    9.4 Mexico Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer
        9.4.1 Mexico Restriction Endonucleases Sales and Market Share by Manufacturer
        9.4.2 Mexico Restriction Endonucleases Revenue and Market Share by Manufacturer
    9.5 Mexico Restriction Endonucleases Export and Import (2012-2017)
10 Restriction Endonucleases Market Forecast (2017-2022)
    10.1 North America Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022)
    10.2 Restriction Endonucleases Market Forecast by Countries (2017-2022)
        10.2.1 United States Restriction Endonucleases Forecast (2017-2022)
        10.2.2 Canada Restriction Endonucleases Forecast (2017-2022)
        10.2.3 Mexico Restriction Endonucleases Forecast (2017-2022)
    10.3 Restriction Endonucleases Market Forecast by Type (2017-2022)
    10.4 Restriction Endonucleases Market Forecast by Application (2017-2022)
11 Restriction Endonucleases Manufacturing Cost Analysis
    11.1 Restriction Endonucleases Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Restriction Endonucleases
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Restriction Endonucleases Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016
    12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Analyst Introduction
    15.3 Data Source

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)4480 View Pricing